These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34284376)
1. Cytological Appearances of Ovarian Seromucinous Borderline Tumor in Ascites: Presentation of 2 Cases. Kai K; Hashiguchi M; Kurihara M; Tanaka Y; Kitamura S; Nakamura M; Shichijo C; Yamamoto-Rikitake M; Okuma R; Hikari T; Okuma E; Uchiyama M; Aoki S; Nakao Y; Yokoyama M; Aishima S Acta Cytol; 2021; 65(5):440-447. PubMed ID: 34284376 [TBL] [Abstract][Full Text] [Related]
2. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors. Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy. Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911 [TBL] [Abstract][Full Text] [Related]
4. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging. Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546 [TBL] [Abstract][Full Text] [Related]
5. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor. Wu RC; Chen SJ; Chen HC; Tan KT; Jung SM; Lin CY; Chao AS; Huang KG; Chou HH; Chang TC; Chao A; Lai CH Mod Pathol; 2020 Dec; 33(12):2534-2543. PubMed ID: 32616873 [TBL] [Abstract][Full Text] [Related]
7. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series. Vroobel KM; McCluggage WG Int J Gynecol Pathol; 2022 Jan; 41(1):76-81. PubMed ID: 33741765 [TBL] [Abstract][Full Text] [Related]
8. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358 [TBL] [Abstract][Full Text] [Related]
9. A diagnostic challenge of seromucinous borderline tumor: A case report. Liu T; Sumida D; Wada T; Maehana T; Yamawaki A; Sugimoto S; Kawahara N; Yoshimoto C; Kobayashi H Medicine (Baltimore); 2019 May; 98(22):e15707. PubMed ID: 31145284 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour. Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic study of seromucinous carcinoma of ovary]. Tang SX; Sun YH; Xu Y; Zhou XR; Yang WT Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):774-779. PubMed ID: 27821232 [No Abstract] [Full Text] [Related]
12. Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination. Nakamura E; Sato Y; Moriguchi S; Yamashita A; Higo T; Asada Y Case Rep Obstet Gynecol; 2015; 2015():690891. PubMed ID: 26075120 [TBL] [Abstract][Full Text] [Related]
13. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach. Talia KL; Parra-Herran C; McCluggage WG Histopathology; 2022 Jan; 80(2):255-278. PubMed ID: 33963606 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Discordance in Intraoperative Frozen Section Diagnosis of Ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese Cancer Center. Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T Int J Surg Pathol; 2021 Feb; 29(1):30-38. PubMed ID: 32955372 [TBL] [Abstract][Full Text] [Related]
15. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature. Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633 [TBL] [Abstract][Full Text] [Related]
17. Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts. Taga Y; Chigusa Y; Minamiguchi S; Kido A; Horikawa N; Horie A; Hamanishi J; Kondoh E; Mandai M; Yamaguchi K Int Cancer Conf J; 2021 Jan; 10(1):46-53. PubMed ID: 33489701 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience. Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas. Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965 [TBL] [Abstract][Full Text] [Related]
20. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Taylor J; McCluggage WG Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]